A Possible Biomarker for COVID-19 Cognitive Impairment

Researchers in Australia identified kynurenine pathway activation as a potential biomarker for evaluating and monitoring patients for cognitive impairment and decline after COVID-19 illness.
First Look

Leave a Reply

Your email address will not be published. Required fields are marked *